Changes in sleepiness and 24-h blood pressure following 4 months of CPAP treatment are not mediated by ICAM-1.

Victoria M PakDavid G MaislinBrendan T KeenanRaymond R TownsendBryndis BenediktsdottirSandra B DunbarAllan I PackThorarinn GislasonSamuel T Kuna

Published in: Sleep & breathing = Schlaf & Atmung (2021)

Changes in ICAM-1 levels were not related to changes in sleepiness or ABPM following CPAP treatment of adults with OSA. Future work should explore whether or not other biomarkers may have a role in mediating these treatment outcomes in adults with OSA.

Keyphrases

obstructive sleep apnea
positive airway pressure
sleep apnea
blood pressure
type diabetes
metabolic syndrome
combination therapy
physical activity
insulin resistance
glycemic control